Tables S1 to S4 as zipped Excel files Supporting Visualization S1 as a zipped .cys file
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Antibodies
Antibodies recognizing APC16 were raised in rabbits against two different synthetic peptides derived from the protein sequence: peptide 2184 (LEADEWRFKPIEQLLGFTPSSG), used for western blotting and peptide 2186 (DLAPPRKALFTYPKGAGEMLEDGSERFLC), used for IP). Further antibodies used in immunofluorescence, immunopurification, western blotting and immnunoprecipitation as indicated were: mouse anti-APC2 (S10), rabbit anti-pAPC6 (S11), rabbit anti-APC10 (S12), rabbit anti-pT288 AURKA (3079S, Cell Signaling), rabbit anti-CDC16 (S12), rabbit anti-CDC27 (S10), mouse anti-Centrin (a kind gift from Dr. Jeffrey Salisbury, Mayo Clinic, Rochester, MN) (S13), rabbit anti-CEP135 (S14), goat anti-EGFP (S1), mouse anti-GFP (11814460001, Roche), rabbit anti-GFP (A-11122, Invitrogen), mouse anti-p97 (S15), rabbit anti-Pericentrin (ab4448, Abcam), mouse anti-PLK1 (F8, Santa Cruz), mouse anti-TUBA1A (T-5168 and T-9126 (DM1A), Sigma), rat anti-alpha-tubulin (MCA77G ABD, Serotec), and rabbit anti-TUBG1 (T-3559, Sigma).
Immunofluorescence microscopy and image processing
Small-scale immunofluorescence microscopy
Cells were grown in duplicate on 11-or 12-mm coverslips in 24-well plates, and each was fixed with 3% paraformaldehyde (PFA) and 2% sucrose, 5 mM ethylene glycol tetraacetic acid (EGTA), and 1 mM MgCl 2 in 1× PBS at RT, and in methanol at -20˚C. After fixation, the cells were permeabilized and blocked in PBS supplemented with 0.2% fish skin gelatin (FSG-PBS) overnight or in 3% BSA in PBS for 30 min. Cells were then stained with primary antibodies in 0.2% FSG-PBS or 3% BSA in PBS, followed by two washes in 0.2% FSG-PBS or 3% BSA in PBS and secondary antibody staining. DNA was counterstained with 100 ng/ml Hoechst 33342 (Calbiochem). Cells were briefly rinsed in water, dried, and mounted onto a glass slide using MOWIOL (Calbiochem) or ProLong Gold (Invitrogen). Images were taken on a wide field microscope (Axioplan 2; Zeiss, Germany) equipped with a CCD camera (CS4742-95, Hamamatsu GmbH, Germany) or a DeltaVision system (Applied Precision) equipped with a CoolSnap HQ CCD camera (Roper Scientific). Images taken on the DeltaVision system were deconvolved and projected.
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Automatic image acquisition
For imaging on a high-throughput automated microscope, 13,000 cells were seeded in triplicate into two 96-well imaging plates (Greiner, Germany) in DMEM medium containing 2 mM thymidine, and were cultured for at least 14 hr. Cells were washed in warm medium, released into medium without thymidine, and fixed in PFA and methanol after 9 hr. After application of primary and secondary antibodies, DNA and cytoplasm were stained with 1 µg/ml Hoechst 33342 and 1 µM SytoBlue 42 (Invitrogen), respectively. The stained plates were imaged on an automated confocal microscope (Opera QEHS, Evotech) with a 20× or 40× water-immersion objective. The output monochrome image stacks were processed to give a color picture using ImageMagick software (www.imagemagick.org).
Localization-based clustering
For localization-based clustering, subcellular locations were pre-defined for each cell-cycle stage. A localization score matrix was generated by counting for each cell pool and each location the proportion of counted cells found in the location (at least 15 cells were counted and the images were recorded for each pool). This matrix was used as input for hierarchical clustering by complete linkage using Kendall's tau for distance measurement, as implemented in Cluster 3.0 software (S16, S17) . Clustering results were visualized with Java TreeView (S18). Sub-clusters were manually defined based on distinctive localization patterns. For the purpose of predicting gene function for unknown genes, each gene was searched in PubMed (www.pubmed.org) for its characterization in mammalian cells. Genes with no reported characterization in PubMed were regarded as "unknown", while characterized genes without any keyword relevant to mitosis in PubMed and the Gene Ontology database (www.geneontology.org)(S19) were regarded as "mitotically unknown".
Biochemical methods
LAP-purification, immunoprecipitation and mass spectrometry analysis
HeLa BAC cell pools were grown on monolayers and arrested in mitosis by nocodazole treatment as previously described (S1), resulting in an 80-90% mitotic population, as judged by cell morphology and DNA staining. LAP-tagged bait and associated proteins were isolated from cell extracts via the two-step purification procedure as described (S1).
Immunoprecipitation using an APC16-specific antibody (see 'Antibodies' section) was 6 performed as described (S20) . Of the sample of eluted protein, 20% was analyzed by SDS-PAGE and silver staining, to visually assess the yield and purity of the preparation. The remaining eluate was reduced, alkylated and trypsinized in solution as described (S21) , then 50% or 100% of this digest, depending on protein abundance, was analyzed by liquid chromatography coupled to tandem mass spectrometry, essentially as described (S21) .
Sucrose density gradient fractionation
Sucrose density gradient fractionation was performed as described (S22) , using a 10-30% continuous gradient and high-speed supernatants of extracts from HeLa cells. Gradient fractions were analyzed by SDS-PAGE and western blotting with the indicated antibodies.
In vitro ubiquitylation assay
Five µl of either APC16 or CDC27, immunopurified from interphase HeLa extracts, was assayed, on antibody beads, for ubiquitylation activity using an [
125 I]-labeled CCNB1 fragment as a substrate, as previously described (S23) .
Localization studies by negative stain immune electron microscopy
Negative-stain immune electron microscopy APC/C particles were isolated from extracts of interphase HeLa cells by immunoprecipitation on CDC27 antibody beads followed by elution with CDC27 peptide, as described (S20).
Purified APC/C was incubated with decreasing concentrations of APC16 antibody (peptide 2186), starting at a molar APC/C to IgG ratio of 2:1. At the antibody concentration yielding a high percentage of APC/C dimers, samples were subjected to glycerol gradient centrifugation using the GraFix procedure (S24) . Purified APC/C-antibody complexes were collected from the GraFix gradient and adsorbed to a thin film of carbon bound to an electron microscopical grid covered with a perforated carbon film. The bound APC/C particles were stained with 2% uranyl formate, blotted and air dried. Images were recorded at a magnification of 115,000× on a 4k × 4k CCD camera (TVIPS GmbH, Germany) using two-fold pixel binning (2.6 Å/pixel) in a Philips CM200 FEG electron microscope (Philips/FEI, Eindhoven, The Netherlands) operated at an acceleration voltage of 160 kV.
Localization of the APC16 antibody
The concentration of APC/C-antibody complexes on the EM grid was chosen to be very low to ensure that APC/C dimers were not formed accidentally by the presence of large amounts of APC/C particles binding next to each other on the carbon film. 348 APC/C dimers were initially selected for the antibody labeling experiment to determine the antibody binding sites.
First the projection direction of APC/C monomers was determined and rectangular planes were drawn in 3D, perpendicular to the imaging plane at the antibody binding site. ~30 rectangular planes were sufficient for antibody localization because they already intersected well in 3D defining a single spot on the surface of APC/C (Fig. 4C ). We were thus able to determine the location of APC16 at an accuracy that is approximately reflected by the size of the sphere shown in Fig. 4C .
Mass spectrometry data processing and clustering analysis
Identification of protein interactors
The identification of peptides from tandem mass spectrum data was performed using Mascot (www.matrixscience.com)(S25), with a custom protein database comprising the total human UniProt (S26), GenBank (S27), DDBJ (S28), EMBL (S29), RefSeq (S30) and Celera (S31) sequences, plus mouse UniProt or Ensembl (S32) entries corresponding to the bait proteins.
Peptide data obtained from Mascot searching were imported into a custom database, and subsequent data handling was performed with a pipeline written in Perl using the MitoCheck database (www.mitocheck.org) application programming interface. Experiments in which no peptide from the bait was detected were discarded. Ensembl 53 (www.ensembl.org) was used as a reference genome.
To map peptides to Ensembl proteins, we looked for proteins that perfectly matched the peptides first in Ensembl then in UniProt entries. Ensembl proteins corresponding to UniProt matches were retrieved using Ensembl's mapping of UniProt entries; the peptides' positions on the corresponding Ensembl protein were identified by Smith-Waterman alignment. For each bait, interactors at the gene level were determined using the parsimony principle (S33).
The criterion for accepting protein identifications was the presence of two or more distinct matching peptides, the tandem mass spectra for each having a Mascot Ions Score of 30 or higher.
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Identification of contaminant proteins
Taking advantage of the standardization work of the Human Gene Nomenclature Committee (HGNC), common contaminants were identified by pattern matching of their HGNC gene symbols to a list of known contaminants (table S2) . In addition, genes found in experiments where the bait was not identified or recovered with more than 10 baits (4.5% of the baits)
were considered contaminants and discarded. In the final dataset, the APC/C was represented by all subunits as baits. To avoid classifying its components as contaminants, 6 experiments using 5 subunits (ANAPC1, ANAPC2, ANAPC5, ANAPC10 and ANAPC13) as baits were arbitrarily removed from the dataset prior to analysis. To also catch uncharacterized genes from contaminant families (e.g. keratins, ribosomal proteins), we also included paralogs of identified contaminants. Paralogs were identified using TreeFam (S34). The complete list of genes removed from the interaction dataset is available in table S3.
Construction of the interaction graph
Following contaminant removal, experiments using the same bait were merged, and interactions represented using the spoke model. For this purpose, mouse bait genes are considered to be identical to their human orthologs. The resulting dataset comprised 239 bait and 936 associated preys. Processing with the Graph Perl module revealed that this dataset formed an interaction graph composed of one large network (comprising 1020 proteins) plus 22 small isolated networks (containing a total of 122 proteins) and 32 singletons (baits with no prey)( fig. S7A ). The large network was then subjected to clustering, as described below.
Complex inference using spectral fuzzy c-means (SFCM)
To identify complexes, we represented the interaction graph using a matrix model where edges between genes are weighted by the number of baits they share. This provided a similarity measure between genes consistent with complex membership, as the more baits two genes have in common, the more likely they are to be in the same complex. Identifying putative complexes in the interaction graph then amounts to finding a partition of the graph such that edges between genes within a group have high similarity and edges between genes from different groups have low similarity. A common solution to this problem is to minimise the normalized cut objective function as introduced by Shi et al. (S35) . To solve this, we took the random walk view of Melia et al. (S36) . First, we formed a binary experiment matrix E by setting E i,j to 1 if protein j is an interactor of bait i or 0 otherwise. From E, we derived the adjacency matrix A = E T E (where A ij is the number of baits shared by i and j) and the 9 corresponding normalized graph Laplacian L = I-D -1 A, where D is the degree matrix of A and I is the identity matrix. A good approximation to the normalized cut is obtained by solving the eigenproblem Lz = λDz, where the eigenvectors z form cluster membership indicators (S35, S36) . Putative complexes were identified by applying a clustering algorithm to the proteins projected in the space defined by the eigenvectors z corresponding to the first k eigenvalues of L. The number of clusters k was determined from the data using the eigengap heuristic or the elbow criterion. To allow proteins to belong to multiple complexes, we performed the clustering step using the fuzzy c-means algorithm. This algorithm associates each protein to all clusters through a membership value between 0 and 1 with values close to 1 indicating strong association. The fuzziness parameter m is determined by plotting the number of clusters per protein for different values of m. We observed a sharp transition between m = 1, where each protein belongs to one cluster, and m = 1.1, where each protein belongs to many clusters. We set m to a value in the lower part of the transition region to reflect our belief that proteins are unlikely to be part of many complexes. In this work, m = 1.03. As m tends to infinity, memberships tend to 1/k. Thus this value represents a weak association, and we assigned proteins to clusters where they have membership >1/k. We ran the fuzzy c-means algorithm at least 20 times with random initializations. The final set of clusters was formed by the largest subclusters common to all runs, to which we added members associated with each subcluster in at least 70% of the runs. We call this algorithm spectral fuzzy c-means (SFCM).
SFCM was implemented in Perl using a custom object-oriented module derived from the JAMA library (http://math.nist.gov/javanumerics/jama/).
To assess SFCM performance, we compared the clusters to 11 known 'reference' complexes ( fig. S6A ), which have members in our data set. We used precision and recall to evaluate the correspondence between the SFCM-derived clusters and the reference complexes. The precision (=intersection(complex,cluster)/cluster) measures the fraction of cluster members belonging to the same complex. A low precision means the clusters have more members than the known complexes. The recall (=intersection(complex,cluster)/complex) measures the fraction of complex members assigned to the same cluster. A high recall means the clusters contain most or all of the known complex members. For the 11 reference complexes present in this data set, our algorithm gave an average precision of 58% and an average recall of 89%. For comparison, the Markov clustering algorithm (MCL)(S37) with an inflation value giving the same number of clusters (I = 1.84) resulted in an average precision of 44% and an average recall of 79%.
Analysis of interaction clusters
Following the SFCM procedure, a list of SFCM-generated clusters with two or more components, plus small isolated networks, was compiled. 
Master map generation
To summarize both localization and physical interaction results, a combined map of the mitotic proteins was generated ( fig. S8 ). This interaction diagram was initially generated S13D ).
Multiple amino-acid sequence alignments were performed using the Multiple Alignment using Fast Fourier Transform (MAFFT) algorithm (S50), and rendered using Clustal X software (S51). Where exact-sequence versions of the NCBI protein entries existed in the Ensembl database, the Ensembl identifiers were used for consistency with the www.mitocheck.org database. To test the validity of using transgenic cell pools rather than clonal cell lines, we determined the proportion of cells within a pool that scored positive for a GFP signal, using immunofluorescence microscopy. 532 BAC cell pools were selected for this analysis, and the ranges of percent GFP-positive cells are plotted against number of cell pools in the bar graph. More than half (51%) of the cell pools showed a GFP-positive percentage higher than 60%, indicating a high consistency of tagged transgene expression from BAC cell pools.
(C) Distribution of the localization of the tagged mitotic proteins. Stably-expressing BAC cell pools were analyzed for the localization of the tagged proteins, and grouped into the following, without redundancy: localization to specific mitotic structures (red), interphase localization (orange), nucleus in interphase (blue), cytoplasm throughout the cell cycle (green), no signal (grey). Examples of cells imaged at different cellcycle stages are shown in Fig. 1B . Note that the number of cell pools analyzed in this experiment is higher than the number of mitotic genes mentioned in Fig. 1A because some genes had been tagged at both the N-and C-termini.
(D) Comparison of the localization of the BAC transgenes tagged at the C-and N-terminus. For 39 genes for which both C-and N-terminal-tagged transgenes were made, their localizations in the cell were compared. Localizations were separated into cytoplasmic and non-cytoplasmic, and a comparison was made for each category. Thirty-five of the 39 genes (90%) showed essentially the same localization, supporting the overall validity of the use of a single terminus for tagging the transgenes. Four of 15 (27%) non-cytoplasmic genes showed different localizations between C-and N-terminally tagged BAC transgenes, which could result from our tagging scheme: C-terminal tag is the primary means, while the N-terminal tag is mostly employed as a backup, used when localization was cytoplasmic or inconsistent with the literature. Figure S2 . Comparison of localization obtained by live-cell and immunofluorescence microscopy (B) Localizations of the 16 tagged transgenes were determined by live-cell imaging and immunofluorescence (IF) microscopy, in three cell-cycle phases: mitosis, telophase, and interphase. For each protein/phase combination, the localization from live-cell movies is described on the left, while localization from IF is on the right. Where the localizations are identical between live-cell movies and IF images, both are shown in bold. Of the 15 proteins detectable in live-cell imaging, 14 showed the same localization by IF microscopy in two or all three phases. This demonstrates that IF microscopy gives essentially the same localization result as live-cell imaging. We also compared our localization results with those reported in the literature. For 53 of 70 proteins with a previously reported localization in mitosis (75%), our data agreed with the literature, 20% partially agreed and only 5% were inconsistent. Figure S3 15 Figure S3 . Localization trajectories of selected protein complexes Shown is a schematic diagram of the localization trajectories for thirteen selected protein complexes through five cell-cycle phases. In order to assess whether prediction of complex formation by protein localization is possible, the proteins showing mitotic localizations were imaged by immunofluorescence microscopy at a higher temporal resolution: in interphase, prophase, prometaphase, metaphase, anaphase, and telophase. The components of the protein complexes were defined based on knowledge from the literature. The localizations of the components of the indicated protein complexes were gathered, and the representative localization patterns of the protein complexes are shown in individually isolated trajectories. Localization is indicated by the following color code: red, kinetochore; orange, spindle microtubule; green, centrosome; magenta, midbody; purple, nuclear envelope; sand, golgi; pale-blue, cortex; sky-blue, cleavage furrow; white, cytoplasm. Where the subunits showed different localizations (e.g. TPX2 and Aurora A in interphase and telophase), they are drawn separately. The generated trajectories indicate that each protein complex exhibits a distinctive localization pattern through the cell cycle stages, enabling protein complexes showing very similar localizations (e.g. γ-TuRC and Augmin/HAUS) to be resolved. Figure S4 16 (A) Immunofluorescence microscopy images of HeLa cells stably expressing the mitoticallyuncharacterized proteins CEP120-LAP and CCDC52-LAP, at different stages of the cell cycle, showing the centrosomal localization of these two proteins in mitosis. Cells were fixed and stained with antibodies against GFP (green), α-tubulin (red) and DNA (blue). Size bars, 10 µm.
CEP120 colocalizes with CCDC52 and is required for centriole duplication
CEP120 is required for nuclear migration in neuronal progenitors (S52) but its cellular function is not well understood. Because CEP120 shared a localization trajectory with several other proteins required for centriole duplication ( Fig. 2 and panel A in this figure) we analyzed the number of centrioles present in mitotic HeLa cells upon CEP120 RNAi. Staining with antibodies to pericentriolar and centriolar proteins (pericentrin and centrin, respectively) revealed that many CEP120 depleted cells contained fewer than two centrioles per spindle pole, as opposed to two in control cells (panels B and C). Analysis of centriole number in HeLa cells expressing an RNAi-resistant murine CEP120-GFP BAC yielded a centriole number largely equivalent to those of control cells, indicating that the phenotype observed is not due to an off-target effect (panel D). We further observed that centriole overduplication, induced after prolonged S-phase arrest, was impaired in U2-OS cells depleted of CEP120 (panel E). Together these results show that CEP120 is required for centriole duplication, as initially suggested by our co-clustering with known regulators of centriole biogenesis. These results suggest that our cluster analysis will help assign putative functions to many of the other 31 partially characterized proteins we have localized, and potentially to many of their associated proteins that we identified by mass spectrometry. esiRNA. The number of centrioles was counted by immunofluorescence microscopy using cells fixed at 72 hr post-transfection and stained with anti-centrin antibodies. Data shown are mean ± SEM of three independent experiments. 50 mitotic cells were counted for each esiRNA treatment in each experiment. There are statistically significant differences in the number of mitotic cells with 4 or fewer centrioles in HeLa cells treated with CEP120 esiRNA compared to control esiRNA (asterisks indicate significance of differences: * = p<0.05; ** = p<0.01). In HeLa expressing mouse CEP120-LAP, no significant differences (p>0.05 for all pairs) were observed in the number of cells with 0, 1, 2, 3, 4 or >4 centrioles. This result indicates that CEP120 is required for centriole duplication and that the mouse BAC transgene containing CEP120 is functional in human cells. Species Bait Overlap
(A) Silver-stained SDS-PAGE gel showing an example set of LAP purifications from extracts of mitotic HeLa cells. This set contained ten LAP-tagged mouse baits, including CDC2 (used as a positive control for each set of LAP purifications). The 'no bait' lane shows a LAP purification from an untransfected HeLa cell extract (used as a negative control). The annotation below the gel indicates that in each case, the corresponding bait protein was identified by LC-MS/MS. In most cases additional interacting proteins were also identified.
(B) Table listing the proteins identified following 27 LAP-MS experiments performed with the LAP-tagged CDC2 (positive control) bait, together with the number of times each was detected. Shown are the proteins identified more than once from these 27 experiments; a further 62 proteins were identified only once. (C) Listed are 26 baits for which two LAP-MS experiments have been performed. Two-letter abbreviations for the species from which the bait proteins were derived are: Hs, Homo sapiens; Mm, Mus musculus. The 'Overlap' value refers to the fraction of the total set of proteins identified from both purifications which were common to both purifications, expressed as a percentage.
Identification of tagged bait and interacting proteins by LAP-MS
Purification-mass spectrometry experiments were typically carried out for eleven baits in parallel (panel A).
The mitotic cyclin-dependent kinase 1, CDC2, was included in each set as a control bait, resulting in 27 independent CDC2 data sets. These, and results obtained in duplicate for 26 other baits, showed that the reproducibility of interaction mapping was high (panels B and C). Figure S6 . Reference complex list and LAP-purification / SFCM performance comparison (A) List of 11 reference complexes used to assess the performance of LAP-purification and SFCM clustering to retrieve known protein complexes. Complex members used as baits are shown in red.
(B) Summary of LAP-purificaction results and SFCM cluster prediction in comparison to reference complexes. The LAP-purification complex recall (i.e. how many known complex components were retrieved per bait) is classified into three categories (full = all components retrieved; partial = bait and at least one component retrieved; no = only bait retrieved) and summarised for all used baits by percent combined LAP recall. Of the 11 complexes, 9 were fully recovered using 1 to 5 baits per complex. The SFCM cluster recall and precision (i.e. the fraction of cluster members belonging to the same complex) are given in the two rightmost columns. To identify previously unknown protein complexes we analyzed the dataset of all interactions between 239 bait and 936 prey proteins for the presence of sets of proteins that are densely connected with each other. First we integrated all data into an interaction graph. This contained 55 connected components, of which 32 were singletons (cases where only the bait had been identified) and 23 isolated networks. Most networks were small (<20 proteins), but one contained 1020 proteins and was therefore subjected to clustering analysis by SFCM. The SFCM procedure allows proteins to be part of multiple clusters and makes no assumption about the "granularity" of the resulting network, in other words it does not assume a certain size or number of clusters. These properties are important because proteins can be subunits of different complexes, and the size and number of complexes in our dataset could not be predicted. SFCM clustering of our 1020-protein network identified 100 clusters. Three of these contained only one protein (SFCM singletons), 84 contained between two and 20 members (small SFCM clusters) and 13 contained more than 20 proteins (large SFCM clusters). For further analyses, we joined the 32 singletons identified in the original interaction graph and the three SFCM singletons into a single group of 35 singletons. Likewise, we added the 23 small interaction networks present in the original interaction graph to the 84 small SFCM clusters to yield a set of 107 small clusters. All 107 small clusters and the remaining 13 large clusters are shown in table S4. 21 Figure S8 . A localization-and interaction-integrated map of mitotic protein complexes This "master map" integrates the protein localization and interaction data described in this study. Each of the 238 proteins is shown as a ball, with its rim indicating its localization using a color code. A combination of localizations is shown as multiple-colored rings (e.g. green and yellow for centrosome and spindle microtubule). The proteins shown are grouped by literature-based knowledge of protein complexes (see fig. S6 for definitions of these complexes). These manually-curated complexes are enclosed by gray lines. Moreover, a number of novel complexes, and new components of known complexes were identified (e.g. CEP170/CEP170L-KIFC3, TPX2-Aurora A-CEP192, CEP120-CCDC52). Novel inter-complex interactions were also found (e.g. between the HAUS and PLK1), which may provide clues to understand how interactions between complexes contribute towards successful cell division. Figure S9 23 Figure S9 . Comparison of the localization of bait-prey pairs If two proteins, identified as bait-prey interactors from affinity-purification -mass spectrometry experiments, genuinely interact in the cell, then one would expect them to show similar if not identical patterns of subcellular localization. To further validate the physical interactions identified in this study, the localization of a set of bait-prey pairs was compared. 122 baits that showed mitotic localizations, or are known to be mitotic proteins, were selected for the analysis. 728 bait-prey pairs, in which self-interaction (bait to bait) was removed, were then compared for their localization in mitosis. For these purposes similar as well as identical mitotic localizations (red) were considered as showing co-localization (e.g. a bait-prey pair of centrosome and centrosome plus spindlemicrotubule localizations was considered 'similar localization'). Cytoplasmic localization (green) is shown separately. The bait-prey pairs showing different localizations are shown in blue. In each localization criterion, the number of the reciprocal interactions was counted and shown in a darker color. Notably, of 223 bait-prey pairs showing identical or similar mitotic localization, 114 (51%) interactions were reciprocal. In contrast, the other bait-prey pairs with cytoplasmic localization and different localizations had only 34 (26% of 132 cytoplasmic localization pairs) and 40 (11% of 373 different localization pairs), respectively. This result indicates that reciprocal protein-protein interactions correlate well with co-localization, and also suggests that the co-localization of two or more proteins to specific mitotic structures may be used to predict their possible physical interaction. 
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Interactions between PLK1, PICH and the RTR complex
Our experiments confirmed a previously reported interaction between Polo-like kinase 1 (PLK1) and PLK1-interacting checkpoint helicase (PICH, also known as excision repair cross-complementing rodent repair deficiency, complementation group 6-like [ERCC6L]), which is located on chromatin bridges in anaphase (S63) . In addition, we observed that PICH, but not PLK1, interacts with subunits of the RecQ helicase (BLM)-topoisomerase III (TOP3A)-RecQ mediated genome instability 1 (RMI1) complex (RTR (S64); Fig. 3 , panels A and B). PICH may thus interact in a mutually exclusive manner with PLK1 or RTR. Consistent with this possibility, we observed that TOP3A is located on chromatin bridges (panel C), where also PICH and BLM are found (S63, S65) , whereas PLK1 could not be detected on such chromatin threads. These observations suggest that PICH and RTR function together on chromatin bridges in anaphase, possibly by decatenating sister chromatids (S65). Figure S12 . Characterization of APC16, a newly-identified subunit of the APC/C (A) Proteins identified following LAP-MS analysis of the APC/C. The APC/C and associated proteins were affinity purified from extracts of mitotic HeLa cells expressing eight LAP-tagged bait subunits, then analyzed by LC-MS/MS. The previously-uncharacterized protein c10orf104 was identified in LAP-purified samples from all eight baits; we refer to this protein as APC16 (gene symbol ANAPC16). Percentages refer to sequence coverages. An asterisk indicates that the protein was identified by a single unique peptide. Identified proteins are grouped as follows: orange, LAP-tagged bait; yellow, previously-identified APC/C subunits; blue, MCC subunits; green, other APC/C-associated proteins.
C Figure S12 Figure S12. Characterization of APC16, a newly-identified subunit of the APC/C (B) Specificity of the anti-APC16 antibody. SDS-PAGE followed by immunoblotting using a rabbit polyclonal anti-APC16 antibody produced an intense band of the predicted migration position. Immunoblots of extracts of HeLa cells incubated for the indicated time following transfection with an siRNA oligonucleotide of sequence specific to APC16 showed an approx 80% reduction in signal intensity compared to a control transfection (CON). In contrast, immunoblots with an anti-APC2 antibody showed no reduction in signal intensity. This indicates that the anti-APC16 antibody does specifically recognize the APC16 protein in HeLa cells.
(C) Analysis of APC16 levels through the cell cycle. HeLa cells were synchronized in S-phase by double thymidine arrest, then released and samples taken at the indicated times for analysis by SDS-PAGE and immunoblotting with anti-Cyclin B1, anti-APC16 and anti-alpha-tubulin (TUBA1B) antibodies. Whereas Cyclin B1 levels dropped dramatically as expected in late mitosis, APC16 levels remained fairly constant throughout the 18-hour timecourse (as did those of TUBA1B), indicating that APC16 levels do not change significantly during the cell cycle. Shown is a field of negatively-stained APC/C particles that were dimerized by APC16 antibodies and visualised by electron microscopy (EM) performed at lowtemperature. The concentration of APC/C on the EM grid was intentionally kept low to make sure that trimeric complexes (two APC/C particles bound to one antibody) were analyzed, and not two APC/C particles which were coincidentally positioned next to each other. (E) Three examples of APC16 antibody-bound APC/C dimers, used to determine the APC16 binding surface on the APC/C. On the left are negatively-stained low-temperature EM images; on the right are pairs of 3D APC/C models (red and yellow), oriented to best fit these EM images. For multiple such pairs, rectangles were modeled to the APC/C 3D structures at the respective binding sites of the APC16 antibody. The main crossing 3D area of all rectangles was used to determine the region on the APC/C structure corresponding to the location of APC16 (Fig. 4D) .
(F) Analysis of APC16 association with the APC/C following high-salt wash-off. APC/C was immunoprecipitated from extracts of HeLa cells using antibodies against CDC27 or APC16, as indicated. Immunoprecipitates were washed in either control buffer 'C' or high-salt buffer 'H' before analysis by SDS-PAGE and immunoblotting with antibodies against APC2, CDC27 and APC16. Whereas the APC2 signal was largely lost following high-salt washing (it is known to dissociate from the APC/C, along with APC11, under these conditions), the APC16 signal was not reduced following high-salt washing, nor was CDC27 (which does not dissociate from APC/C in high salt). This indicates that APC16 associates with the rest of the APC/C independently of the APC2 and APC11 subunits. (-BI) . Cells in the leftmost and middle columns were stained with GFP antibodies (green) and DAPI (red) to highlight the LAP-tagged proteins and DNA, respectively; the rightmost column shows the same cells as in the middle column, but stained with antibodies against the centrosomal protein CEP135. PLK1-inhibitor treatment resulted in a phenotype whereby TUBG1-LAP, MOZART2B-LAP and MOZART1-LAP localization to a discrete pair of dots (centrosomes) was lost, showing instead a more diffuse localization. The CEP135 staining at two discrete points after PLK1-inhibitor treatment indicates that the centrosomes themselves remained intact under these conditions. These data suggest that the activity of PLK1 is required for the correct centrosomal localization of MOZART1 and MOZART2B. Scale bars, 10 µm.
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GFP + DAPI CEP135
-BI +BI +BI ......10........20........30........40........50... ------------------------------------------------------------MLANKLKTTHNVHQK---- Figure S13 . Characterization of MOZART1 and MOZART2B: two proteins associated with the γ-TuRC (C) MAFFT multiple amino-acid sequence alignment of predicted orthologs of human MOZART1. Twoletter species abbreviations are as follows: Hs, Homo sapiens; Mm, Mus musculus; Gg, Gallus gallus; Xt, Xenopus tropicalis; Dr, Danio rerio; Tn, Tetraodon nigroviridis; Ci, Ciona intestinalis; Dm, Drosophila melanogaster; At, Arabidopsis thaliana; Cr, Chlamydomonas reinhardtii; Ol, Ostreococcus lucimarinus; Gl, Giardia lamblia; Pt, Paramecium tetraurelia; Cn, Cryptococcus neoformans; Sp, Schizosaccharomyces pombe. The presence of longer regions that do not align with the other sequences is indicated by the number of amino acid residues in square brackets. (D) MAFFT multiple amino-acid sequence alignment of predicted orthologs of human MOZART2A and MOZART2B. These two human proteins are paralogous, probably the result of a gene duplication event during primate evolution. For the non-human species shown only one ortholog of MOZART2A/B could be identified. Two-letter species abbreviations (in addition to those described in part B) are as follows: Nv, Nematostella vectensis; Sj, Schistosoma japonicum. The presence of longer regions that do not align with the other sequences is indicated by the number of amino acid residues in square brackets. (E) HeLa cells either control treated, transfected with siRNA specific for TUBG1 or MOZART1, or treated for one hour with the PLK1 inhibitor BI 2536, were fixed and stained with DAPI (cyan) and pAPC6 antibody (red). Note that centrosomal PLK1 activity is not changed upon MOZART1 depletion. Scale bar, 10 µm. (F) HeLa cells either control treated, transfected with siRNA specific for TUBG1 or MOZART1, or treated for one hour with BI 2536 were fixed and stained with DAPI (cyan) and pT288-AURKA antibody (red). Note that centrosomal AURKA activity is not changed upon MOZART1 depletion. Scale bar, 10 µm. 
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